Last week, the overall A-share market fluctuated sideways. There was a clear recovery in the technology sector, but institutional enthusiasm remained undiminished. Technology stocks such as Shengbang Co., Ltd., Fenghua Hi-Tech, and Yuanjie Technology all received research from over 100 institutions. Among them, Shengbang Co., Ltd. received research from 272 institutions; A-share medical device leader Mindray Healthcare also received research from 253 institutions after the disclosure of the 2026 semi-annual report. Currently, prices of various electronic components have risen markedly. Regarding the question of whether there are plans to increase prices, Shengbang Co., Ltd. stated that the company has maintained continuous revenue growth by continuously broadening the product matrix and increasing the total number of products, continuously expanding application areas and expanding the customer base, and has maintained a relatively stable average gross margin through dynamic adjustment of the product portfolio. The company currently has no comprehensive price increase plans, and will keep an eye on the situation in the future.

Zhitongcaijing · 2d ago
Last week, the overall A-share market fluctuated sideways. There was a clear recovery in the technology sector, but institutional enthusiasm remained undiminished. Technology stocks such as Shengbang Co., Ltd., Fenghua Hi-Tech, and Yuanjie Technology all received research from over 100 institutions. Among them, Shengbang Co., Ltd. received research from 272 institutions; A-share medical device leader Mindray Healthcare also received research from 253 institutions after the disclosure of the 2026 semi-annual report. Currently, prices of various electronic components have risen markedly. Regarding the question of whether there are plans to increase prices, Shengbang Co., Ltd. stated that the company has maintained continuous revenue growth by continuously broadening the product matrix and increasing the total number of products, continuously expanding application areas and expanding the customer base, and has maintained a relatively stable average gross margin through dynamic adjustment of the product portfolio. The company currently has no comprehensive price increase plans, and will keep an eye on the situation in the future.